August 28, 2017
Weil advised Sanofi in its $750 million acquisition of Protein Sciences, a privately held vaccines biotechnology company based in Meriden, Connecticut. The transaction closed August 28, 2017.
The Weil team that advised Sanofi was led by Mergers & Acquisitions partner Michael Aiello and Private Equity partner Shayla Harlev and included Corporate associates Christina De Vuono, Hayden Guthrie, Aamir Rahman and Brianna Dollinger. The team also included Technology & IP Transactions partner Jeffrey Osterman; Tax partner Chayim Neubort; Executive Compensation & Benefits partner Amy Rubin; Antitrust partner John Scribner; Complex Commercial Litigation partner Yehudah Buchweitz; Antitrust counsel Michael Naughton; Technology & IP Transactions associates Jennifer Yoon and Dennis Adams; Tax associate Scott Fryman; Executive Compensation & Benefits associate Zahava Blumental; and Antitrust associate Christopher Abbott.